Goto H, Wells K, Takada A, Kawaoka Y
Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.
J Virol. 2001 Oct;75(19):9297-301. doi: 10.1128/JVI.75.19.9297-9301.2001.
When expressed in vitro, the neuraminidase (NA) of A/WSN/33 (WSN) virus binds and sequesters plasminogen on the cell surface, leading to enhanced cleavage of the viral hemagglutinin. To obtain direct evidence that the plasminogen-binding activity of the NA enhances the pathogenicity of WSN virus, we generated mutant viruses whose NAs lacked plasminogen-binding activity because of a mutation at the C terminus, from Lys to Arg or Leu. In the presence of trypsin, these mutant viruses replicated similarly to wild-type virus in cell culture. By contrast, in the presence of plasminogen, the mutant viruses failed to undergo multiple cycles of replication while the wild-type virus grew normally. The mutant viruses showed attenuated growth in mice and failed to grow at all in the brain. Furthermore, another mutant WSN virus, possessing an NA with a glycosylation site at position 130 (146 in N2 numbering), leading to the loss of neurovirulence, failed to grow in cell culture in the presence of plasminogen. We conclude that the plasminogen-binding activity of the WSN NA determines its pathogenicity in mice.
在体外表达时,A/WSN/33(WSN)病毒的神经氨酸酶(NA)在细胞表面结合并隔离纤溶酶原,导致病毒血凝素的裂解增强。为了获得直接证据证明NA的纤溶酶原结合活性增强了WSN病毒的致病性,我们构建了突变病毒,其NA由于C末端从赖氨酸突变为精氨酸或亮氨酸而缺乏纤溶酶原结合活性。在胰蛋白酶存在的情况下,这些突变病毒在细胞培养中的复制情况与野生型病毒相似。相比之下,在纤溶酶原存在的情况下,突变病毒无法进行多轮复制,而野生型病毒则正常生长。突变病毒在小鼠体内的生长减弱,在脑中完全无法生长。此外,另一种突变的WSN病毒,其NA在第130位(N2编号为146位)具有一个糖基化位点,导致神经毒力丧失,在纤溶酶原存在的情况下在细胞培养中无法生长。我们得出结论,WSN NA的纤溶酶原结合活性决定了其在小鼠中的致病性。